 Antiviral Agents
"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 1 | 4 | | 1997 | 7 | 2 | 9 | | 1998 | 4 | 2 | 6 | | 1999 | 1 | 0 | 1 | | 2000 | 4 | 0 | 4 | | 2001 | 3 | 2 | 5 | | 2002 | 6 | 3 | 9 | | 2003 | 7 | 0 | 7 | | 2004 | 8 | 6 | 14 | | 2005 | 5 | 4 | 9 | | 2006 | 7 | 3 | 10 | | 2007 | 11 | 7 | 18 | | 2008 | 7 | 5 | 12 | | 2009 | 8 | 7 | 15 | | 2010 | 11 | 6 | 17 | | 2011 | 11 | 10 | 21 | | 2012 | 14 | 2 | 16 | | 2013 | 17 | 1 | 18 | | 2014 | 10 | 5 | 15 | | 2015 | 25 | 11 | 36 | | 2016 | 23 | 5 | 28 | | 2017 | 15 | 7 | 22 | | 2018 | 19 | 7 | 26 | | 2019 | 20 | 10 | 30 | | 2020 | 22 | 15 | 37 | | 2021 | 22 | 13 | 35 | | 2022 | 9 | 32 | 41 | | 2023 | 2 | 18 | 20 | | 2024 | 15 | 8 | 23 | | 2025 | 20 | 3 | 23 | | 2026 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Baker JV, Siegel LK, Losso MH, Vasudeva S, Nordwall JA, Harper K, Grund B, Havens JP, Fletcher CV, Fishchuk R, Kobrynska O, Abutidze A, Metchurtchlishvili R, Ginde AA, Aggarwal NR, Poulakou G, Mourad A, Gibbs KW, Saito S, Chayakulkeeree M, Mootsikapun P, Honda H, Mateu L, Gyrina O, Garcia A, Lee DG, Casey JD, Jain MK, Bengtson CD, Hite RD, Hiranburana N, Matthay MA, Arizmendez N, Nguyen HH, Drelick A, Mena Lora AJ, Parnia S, Trautner BW, Portsmouth SD, Shimizu R, Uehara T, Paredes R, Goodman AL, Vock DM, Gelijns AC, Weintrob AC, Bajema KL, Pett SL, Lundgren J, Schechner AJ, Higgs ES, Lane HC, Matthews GV, Self WH, Reilly C. Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial. Clin Infect Dis. 2026 Jul 23; 83(1):59-69.
-
Chappell CA, Brooks KM, Kiser JJ, Klein B, Nerguizian D, Bushman L, Laird HJ, Stewart E, Kasula K, Kwon KM, Letterio C, Naik S, Kreter B, Krans EE. Sofosbuvir/Velpatasvir Concentrations in the Breastmilk of Postpartum Women With Opioid Use Disorder Receiving Treatment for Hepatitis C Virus: A Pharmacokinetic Study. Clin Infect Dis. 2026 Jul 08; 82(6):993-996.
-
Azziz-Baumgartner E, Budd A, Lee JS, Iuliano AD, Ellington SR, Levine MZ, Zheng XY, Gubareva L, Adams K, DeCuir J, Bozio CH, Reed C, Kirby MK, Rambo-Martin B, Jones JM, Biggerstaff M, Garg S, Davis CT, Shimabukuro TT, Burns E, Kondor R, Olsen SJ, Dugan VG, Irving SA, Naleway AL, Dascomb K, Sheffield T, DeSilva MB, Tartof SY, Sy LS, Klein NP, Zerbo O, Grannis SJ, Dixon BE, Stockwell MS, Stephens AB, Ong TC, Barron MA, Ball SW, Weber ZA, Reeves EL, Ray CS. Influenza Activity and Estimated Vaccine Effectiveness During the 2025-2026 Influenza Season. JAMA Netw Open. 2026 Jun 01; 9(6):e2618581.
-
Hecht CJS, Parker RR. RK-33 inhibits the OC43 coronavirus and induces stress granules via DDX3X-independent mechanisms. RNA. 2026 04 16; 32(5):724-735.
-
Li K, Rudy MJ, Klose T, Tan H, Wu X, Demssie HA, Anderson JS, Jadhav P, Zhang QY, Clarke P, Kuhn RJ, Tyler KL, Wang J. Rational design and in vivo validation of capsid inhibitors for enterovirus D68. Nat Commun. 2026 Feb 10; 17(1).
-
Kim AY, Kang M, Umbleja T, Nunes EP, Marks KM, Luetkemeyer AF, Koebele C, Wimbish C, Fierer DS, Kliemann DA, Solomon SS, Kort J, Kiser JJ, Lauer GM, Chung RT, Sowah LA, Alston-Smith BL, Wyles DL, Naggie S. Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C. Clin Infect Dis. 2026 02 04; 81(6):1083-1090.
-
Shah MM, Abedi GR, Lu S, Garcia-Knight M, Pineda-Ramirez J, Goldberg SA, Grijalva CG, Keipp Talbot H, Schmitz J, Lutrick K, Ellingson KD, Stockwell MS, Sano E, Nguyen HQ, Rao S, Asturias EJ, Suthar MS, Mellis AM, Deeks SG, Martin JN, Peluso MJ, Andino R, Rolfes MA, Kirking HL, Smith-Jeffcoat SE, Midgley CM, Hagen MB, Kelly JD. SARS-CoV-2 infectious shedding and rebound among adults with and without oral antiviral use: two case-ascertained prospective household studies. Lancet Microbe. 2026 Jan; 7(1):101227.
-
Sears JD, Popov KI, Sylvester PA, Dickmander R, Diaz J, Chang CK, Huff J, Sanders W, Saba NA, Sorensen M, Drobish AM, May NA, Namitz K, Fecko J, Yennawar NH, Morrison TE, Tropsha A, Heise MT, Moorman NJ. Novel computational pipeline to identify target sites for broad spectrum antiviral drugs. Antiviral Res. 2026 01; 245:106322.
-
Concannon K, Page R, Swayngim R, Ambardekar AV, Chiu CY, Schoeppler K, Sartain E. Low-Dose Valganciclovir for Primary Cytomegalovirus Prophylaxis After Heart Transplant: A 10-Year Experience. Clin Transplant. 2025 Dec; 39(12):e70408.
-
Adams K, Garg S, Tartof SY, Irving SA, DeSilva MB, Klein NP, Natarajan K, Dascomb K, Grannis SJ, Ong TC, Salas SB, Sy LS, Lewin B, Qian L, Naleway AL, Koppolu PD, McEvoy CE, Akinsete O, Essien I, Fireman B, Zerbo O, Jacobson KB, Timbol J, Neelam V, Reeves EL, Dickerson M, Ray C, Link-Gelles R, Mak J, Ball SW, O'Reilly M, Olsen SJ, Tenforde MW. Patterns in Prescribing and Dispensing Influenza Antivirals Among Adults With Influenza Presenting to Urgent Care and Emergency Department Settings: VISION Network, 2023-2024. Clin Infect Dis. 2025 11 06; 81(4):e172-e183.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|